YRC Worldwide Reports Second Quarter 2017 Results
Aug 03, 2017 20:02 pm UTC| Business
OVERLAND PARK, Kan., Aug. 03, 2017 -- YRC Worldwide Inc. (NASDAQ:YRCW) reported consolidated operating revenue for second quarter 2017 of $1.261 billion and consolidated operating income of $50.0 million, which included...
L.B. Foster Reports Second Quarter Operating Results
Aug 03, 2017 20:02 pm UTC| Business
PITTSBURGH, Aug. 03, 2017 -- L.B. Foster Company (NASDAQ:FSTR), a leading manufacturer and distributor of products and services for transportation and energy infrastructure, today reported second quarter 2017 net income...
Navigators Reports Second Quarter 2017 Earnings
Aug 03, 2017 20:02 pm UTC| Business
STAMFORD, Conn., Aug. 03, 2017 -- The Navigators Group, Inc. (NASDAQ:NAVG) reported Net Income of $20.5 million, or $0.69 per diluted share, for the three months ended June 30, 2017 compared to $16.2 million, or $0.54...
Allscripts to acquire McKesson’s Enterprise Information Solutions business
Aug 03, 2017 20:01 pm UTC| Business
CHICAGO, Aug. 03, 2017 -- Allscripts (NASDAQ:MDRX), a global leader in healthcare technology, today announced a definitive agreement to acquire McKesson Corporation’s (NYSE:MCK) hospital and health system IT business,...
Aug 03, 2017 20:01 pm UTC| Business
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Aug. 03, 2017 -- Applied Genetic Technologies Corporation (NASDAQ:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene...
Uniti Group Inc. Reports Second Quarter 2017 Results
Aug 03, 2017 20:01 pm UTC| Business
Revenues of $213.0 Million; Net Loss of $0.11 Per Diluted Common Share AFFO Per Diluted Common Share of $0.60 For the QuarterCompleted Acquisitions of Southern Light and Hunt Telecommunications LITTLE ROCK, Ark., Aug. ...
Agios to Present at the Canaccord Genuity 37th Annual Growth Conference Thursday, August 10, 2017
Aug 03, 2017 20:01 pm UTC| Business
CAMBRIDGE, Mass., Aug. 03, 2017 -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the company is scheduled to...